Acetaminophen: The official announcement linking Tylenol, a popular pain medicine with autism was made by President Donald Trump on Monday. In the announcement, he noted that the US Food and Drug Administration (FDA) will notify doctors that the use of Tylenol during pregnancy can be associated with a "very increased risk of autism", despite years of research and evidence that clearly point its safety.

"They are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary," such as to treat fever, "if you can't tough it out," said Trump.

Read: What Is Leucovorin - The Drug Trump Suggests As A Treatment For Autism?

Tylenol, Pregnancy, And Childhood Autism

As per earlier studies, one of which is published in American Family Physician in 2014 also noted that during pregnancy most people used acetaminophen, sold under the brand name Tylenol. Acetaminophen is considered the one safe over-the-counter option for pain or fever for pregnant people. Other common pain relief options like ibuprofen or regular-dose-aspirin is available, however, they can pose serious risk in pregnancy and could lead to complications.

Is There Any Evidence That Show The Link Between Tylenol And Autism?

As per a recent 2024 study published in JAMA Network, titled Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability, there is no risk of autism for mothers who consume the medicine during pregnancy. The study notes: "Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analyses."

James Cusack, chief executive of Autistica, a UK autism research and campaigning charity in London, who is autistic told Nature: "There is no definitive evidence to suggest that paracetamol use in mothers is a cause of autism, and when you see any associations, they are very, very small. At the heart of this is people trying to look for simple answers to complex solutions.”

Helen Tager-Flusberg, a psychologist who studies autism at Boston University, Massachusetts told Nature, "he better controlled studies are less likely to find even a small risk. And even then, what we're talking about is a minor association. … We do not think that taking acetaminophen is in any way contributing to actually causing autism.”

A study led by Viktor Ahlqvist, an epidemiologist at the Karolinska Institute in Stockholm (mentioned above, published in JAMA Network) is considered one of the biggest studies in this subject have also found no such link.

Ahlqvist’s team analyzed data from nearly 2.5 million children born in Sweden between 1995 and 2019, drawing from the nation’s detailed health records. These included acetaminophen prescriptions during pregnancy, self-reported use collected by midwives, and later autism diagnoses in children.

The findings showed autism in about 1.42% of children exposed to acetaminophen prenatally, compared to 1.33% among those not exposed, a difference Ahlqvist described as “very small.”

However, a previous study from 2022, published in Cureus, titled A Systematic Review of the Link Between Autism Spectrum Disorder and Acetaminophen: A Mystery to Resolve, concluded that "using acetaminophen during pregnancy was associated with attention problems and poorer executive development in children, especially with a longer duration of acetaminophen use". The studied reviewed 16 previously published studies and noted: "All 16 studies selected in our data showed a consistent association between acetaminophen and adverse neurodevelopmental outcomes."

Also Read: Tylenol And Autism: Trump, RFK Jr., And Officials To Link The Two In An Announcement Soon

What More Was Discussed In The Announcement?

At the White House, President Trump appeared alongside US Health and Human Services Secretary Robert F. Kennedy Jr., FDA Commissioner Dr. Marty Makary, NIH Director Dr. Jay Bhattacharya, and CMS Administrator Dr. Mehmet Oz. While the discussion included concerns over Tylenol use during pregnancy, Trump went further, calling for delays in childhood vaccinations, even suggesting postponing the hepatitis B shot, which has helped nearly eliminate infections in children, until age 12.

“It’s too much liquid, too many different things are going into that baby,” Trump said, offering no evidence to support his claims.

Scientific consensus remains firm: extensive research has shown no connection between vaccines and autism.

Trump praised Kennedy for bringing autism “to the forefront of American politics” and claimed, “We understood a lot more than a lot of people who studied it.” Kennedy, a longtime vaccine skeptic, has promoted theories linking vaccines to autism that experts widely dismiss.

By contrast, Kennedy and the FDA delivered more measured messages. Kennedy announced that HHS will launch a national campaign to inform families about safe Tylenol use during pregnancy. He stressed that acetaminophen should be used only when necessary, at the lowest effective dose, and for the shortest duration possible.

The FDA said it will begin revising acetaminophen safety labels and issue a letter to physicians. The agency emphasized that while some studies have noted an association, no causal link to autism has been proven, and decisions about Tylenol use remain with parents.

Tylenol’s manufacturer, Kenvue, strongly rejected any claim that acetaminophen causes autism, warning that misinformation could endanger pregnant women. “Acetaminophen is the safest pain reliever option for pregnant women throughout their entire pregnancy,” the company said, adding that untreated fever and severe pain can pose serious risks to both mother and baby.

Kenvue also urged expectant mothers to consult healthcare professionals before using any over-the-counter medication.

While TrumpRx is making headlines for lowering the prices of popular weight loss drugs, something else has also grabbed attention of many. A video from the Oval Office from the Thursday Press Conference when President Donald Trump was announcing the deal with the drugmakers, a man had collapsed. Many claimed that the person who collapsed was Gordon Findlay, who is Novo Nordisk's executive. Dr Mehmet Oz, an American present and a physician was swift to check on the man who had collapsed. Independent journalist Eric Daugherty shared the video and wrote: "A man just passed out during President Trump's Oval Office announcement. Dr Oz Sprung into action and assisted him. Pray for him."

Also Read: TrumpRx: Will Trump’s New Website Make Prescription Drugs More Affordable?

Is The Man Gordon Findlay?

The reason why many have identified the man as Gordon Findlay because in the video, David Ricks, CEO of Eli Lily could be heard asking, "You okay? Gordon, you okay?" Upon this, the White House Press Secretary Karoline Leavitt said in the statement that "a representative with one of the companies fainted". However, no names were given.

Also Read: TrumpRx Lowered Prices Of Popular Weight Loss Drugs; What More Does Trump's New Medical Website Offer?

Novo Nordisk later clarified the claims, and in a statement to Newsweek, the company said, "Please be aware that CEO Mike Doustdar and EVP, US operations, Dave More were the only two Novo Nordisk representatives in the Oval Office."

Dr Oz had previously also helped out at the Oval office in April, when a child fainted while he was being sworn in. A woman, who many media outlets claimed, appeared to be Oz's daughter, Daphne, escorted the girl who had fainted. Later, the White House official confirmed to Fox News Digital that the girl was family member of Oz and had recovered.

What To Do When Someone Collapses?

If someone collapses in front of you, the first need is for someone to try simple CPR or cardiopulmonary resuscitation, while medical help is on its way. What must one keep in mind if someone collapses?

Check for any danger around the person, and give the shoulders of the person who collapsed a shake. Ask them if they can hear you, notes BBC.

If there is no response, tilt their head back to ensure that the airway is clear. This may be enough for the person to again start breathing.

If they are not breathing, this is when CPR becomes important.

Also Read: Trump Strikes Agreement To Cut Costs of Popular Weight Loss Drugs: All You Need to Know

How To Do CPR The Right Way?

As per NHS, UK, there are two correct ways to practice CPR on adults:

Hands-only CPR

This is to be carry out as a chest compression

• Start with kneeling next to the person and place the heel of your hand on the breastbone at the centre of their chest. Place the palm of your other hand on top of the hand that is on their chest and interlock your fingers.
• Position yourself so your shoulders are directly above your hands.
• Using your body weight (not just your arms), press straight down by 5 to 6cm (2 to 2.5 inches) on their chest.
• Keeping your hands on their chest, release the compression and allow their chest to return to its original position.
• Repeat these compressions at a rate of 100 to 120 times a minute until an ambulance arrives or for as long as you can.

CPR with rescue breaths

• Place the heel of your hand on the center of the person's chest, then place the palm of your other hand on top and press down by 5 to 6cm (2 to 2.5 inches) at a steady rate of 100 to 120 compressions a minute.
• After every 30 chest compressions, give 2 rescue breaths.
• Tilt the person's head gently and lift the chin up with 2 fingers. Pinch the person's nose. Seal your mouth over their mouth and blow steadily and firmly into their mouth for about 1 second. Check that their chest rises. Give 2 rescue breaths.
• Continue with cycles of 30 chest compressions and 2 rescue breaths until they begin to recover or emergency help arrives.

Ozempic is about to go on sale! With TrumpRx, a website announced by the US President Donald Trump will allow Americans to buy popular weight loss drugs at a cheaper rate. The drugmakers Eli Lilly and Novo Nordisk have agreed to match prices to the lowest paid in peer nations for all their drugs in Medicaid and for the list prices when their medications first hit the market. They will be offering primary care medicines that will reach to customers directly at a discounted price.

While popular weight loss drugs could be bought from the website at as lowest as $149 per month, what else does TrumpRx offer?

In his own words, "By taking this bold step, we are ending the era of global price gouging at the expense of American families."

Not just Novo Nordisk and Eli Lilly, in fact, it was Pfizer, which is the first US pharmaceutical group that signed up to the website. The company said that it would offer discounts of up to 85%. This is for the medicines for those not using health insurance policies to pay and for those on the government's low-cost insurance programme - Medicaid.

When Will TrumpRx Be Launched?

The plan is to launch the website in early 2026 from where consumers could buy prescribed medicines directly from pharmaceutical companies without having to go through insurance. This is also to aid those under the Medicaid programme, which is a federal government programme for adults and children from lower-income backgrounds. The beneficiaries will have access to the drugs at a discounted prices, which is closer to those paid by national health services in foreign countries, known as the "most favoured nation" prices.

What Does "Most Favoured Nation" Prices Mean?

"Most Favoured Nation" or MFN prices are those that the national health services in countries including Canada, France, Germany, Italy, Japan, the United Kingdom, Switzerland and Denmark pay the US pharmaceutical companies for prescribed drugs.

Since these medicines are exported in a bulk, the prices are lowered as the purchasing power is greater to demand of the ordinary consumers. This is why pharmaceutical companies tend to sell their drugs at a lower price outside than in their own country. Earlier this year in May, Trump, thus signed an executive order that aimed at reducing prescription drug prices in the US. He stated, "The United States will no longer subsidise the health care of foreign countries.”

How Does TrumpRx Play A Role?

Apart from the lower drug prices of popular weight loss drugs, Trump, in July had sent letters to CEOs of 17 pharmaceutical companies and ordered them to reduce their prices, based on certain promises from his end, which included:

Manufacturers will be provided with an avenue to cut out middlemen and sell medicines directly to patients

Manufacturers will be supported by trade policy in raising prices internationally

Trump had also announced new 100% tariffs on imported, branded pharmaceutical products, which will allow him to deliver the second promise.

How Will TrumpRx Benefit People?

As per a 2022 study commissioned by the Office of the Assistant Secretary for Planning and Evaluation, which is published on the US government website, the standard insulin prices in the US are 10 times higher than the prices in 33 OECD countries (Organisation for Economic Cooperation and Development). Lowering of the prices of drugs domestically, and removing the middle men could bring the prices down.

The study also found that the average gross prices in US were more than 10 times the price in France, and the United Kingdom. The prices further skyrocketed by nine times in Italy, eight times the prices in Japan, seven times the prices in Germany, and more than six times in Canada.

While many people who take insulin already pay a "net price", which is lower than the standard price, however, the net price is still 2.33 times the price paid in other countries.

TrumpRx, thus, could benefit anyone who buys drugs directly from the website. This is especially for those who do not have a health insurance in the US. As per a 2024 report from the US Census Bureau, around 8%, which makes 26 million of the US population, do not have a health insurance.

Which Medicines Will Be Sold Through TrumpRx?

Apart from Eli Lilly and Novo Nordisk's popular weight loss drugs like Zepbound, Ozempic and Wegovy, Pfizer too has shared a list of primary-care medicine, not limited to the following:

• Eucrisa: topical ointment for atomic dermatitis at an 80% discount
• Xeljanz: an oral medication for types of arthritis at a 40% discount
• Zavzpret: a drug to treat migraines at a 50% discount
• Duavee: to treat menopause symptoms at around an 85% discount.
• Toviaz: a drug for overactive bladder.

TrumpRx: US President Donald Trump had announced this week that his administration plans to roll out a new website, called TrumpRx, which will allow Americans to purchase prescription medications from pharmaceutical companies at discounted rates.

In a major step to address rising drug costs, the Trump administration also unveiled agreements with Eli Lilly and Novo Nordisk to reduce prices for popular GLP-1 medications like Ozempic, Wegovy, and Zepbound. These deals, part of the TrumpRx initiative, are expected to make the drugs more affordable for Medicare, Medicaid, and direct consumers starting in 2026.

Also Read: TrumpRx Lowered Prices Of Popular Weight Loss Drugs; What More Does Trump's New Medical Website Offer?

Trump Annoucement Today: What Is TrumpRx?

TrumpRx is an online platform designed to let consumers buy prescription medicines directly from the manufacturers, bypassing insurance intermediaries. The website is scheduled to launch in early 2026. Users will be able to search for the specific drug they need and be directed to the drug’s manufacturer, according to USA Today. The platform will offer prices closer to what national health services pay in other countries, following the principle of “most favoured nation” pricing. Medicaid beneficiaries—federal insurance for low-income adults and children—will also have access to the platform.

Also Read: Trump Strikes Agreement To Cut Costs of Popular Weight Loss Drugs: All You Need to Know

TrumpRx: Will The New Website Slash Prescription Drug Prices?

The website is part of a broader effort by Trump to curb high prescription drug costs in the US. In July, he sent a letter to the CEOs of 17 pharmaceutical companies demanding lower prices.

In the letter, he outlined several key points:

• Manufacturers must provide MFN (most favoured nation) prices to all Medicaid patients.
• Companies must ensure that new drugs are not sold at lower prices in other developed nations than in the US.
• Manufacturers will have an option to sell directly to patients, cutting out middlemen, but prices cannot exceed the lowest rates in other developed countries.
• Trade policies will be leveraged to support higher international pricing, with any additional revenue abroad reinvested to reduce costs for American consumers and taxpayers.

TrumpRx: Who Will Benefit Most From This Platform?

Anyone looking to buy prescription drugs directly from manufacturers, rather than through insurance, could benefit. A 2024 US Census Bureau report noted that 8% of Americans (about 26 million people) lacked health insurance in 2023, meaning they could significantly benefit from lower prices. Medicaid may also benefit, as its deal with Pfizer offers better pricing terms. Details about how this part of the program will work are not fully clear yet. Since most Americans rely on insurance for healthcare, experts believe initial adoption of the site may be limited.

TrumpRx: Trump Announces Deal With Drugmakers to Lower Cost of Weight-Loss Drugs

On Thursday, President Trump announced deals with Novo Nordisk and Eli Lilly to cut costs for the lowest doses of their popular weight-loss drugs, lowering barriers for new patients seeking treatment. Beyond government programs, the same GLP-1 drugs will be available directly to consumers via TrumpRx.gov, launching in January 2026.

The starting doses of injectable Wegovy and Zepbound will cost $350 per month but are expected to trend down to $245 over two years. Oral versions, including Novo Nordisk’s upcoming semaglutide pill and Eli Lilly’s orforglipron, will start at $149 per month once approved.